Organization
Sarepta Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Sarepta Therapeutics, Inc.
... of a $22.0 million (£17.2 million) development milestone payment received from Sarepta Therapeutics Inc. (-Sarepta') in June 2017. This announcement contains inside information for the ...
... CAMBRIDGE, Mass., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... on Monday to revive their securities class action claiming executives at Sarepta Therapeutics Inc. selectively omitted facts and misled investors in 2014 about the clinical ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... shareholders of Morgan Stanley (NYSE:MS), TripAdvisor, Inc. (NASDAQ:TRIP), Xerox Corporation (NYSE:XRX), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Semgroup Corporation (NYSE:SEMG), and Toll Brothers Inc. (NYSE:TOL), including updated ...
... CAMBRIDGE, Mass. - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... November 6, 2017 due to his appointment as President and CEO of Sarepta Therapeutics earlier this year. "I'm pleased to welcome Dr. Mansukani to the ...
... Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... for DMD -- CAMBRIDGE, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass. - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass. - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... $155 million -- CAMBRIDGE, Mass., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass. - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial stage biopharmaceutical company focused on the discovery and ...
... CAMBRIDGE, Mass., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... upholding the dismissal of a putative securities class action accusing drugmaker Sarepta Therapeutics Inc. of misleading investors over the possibility of government approval for its ...
... Technologies Inc.Phalanx Biotech Group Inc.Qiagen NvRegulus Therapeutics Inc.Roche Applied SciencesRosetta Genomics Ltd.Sarepta Therapeutics Inc.Theradiag SaThermo Fisher Scientific Inc.Takara Bio Inc.WAKO Pure Chemical Industries Ltd. 12: ...
... muscle biopsy samples. This protocol builds on the processes developed by Sarepta Therapeutics Inc. These muscle biopsy biomarker techniques and the biopsy handling protocol are ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... today announced that the Company will present data from the Catabasis and Sarepta joint research collaboration in Duchenne muscular dystrophy (DMD) at the 22nd International ...
... CAMBRIDGE, Mass. - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial stage biopharmaceutical company focused on the discovery and ...
Want to see the full history on Sarepta Therapeutics, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial